Toggle Main Menu Toggle Search

Open Access padlockePrints

WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression

Lookup NU author(s): Dr Florence Burte, Dr Holly Duncan, Professor Patrick Chinnery

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2022 The Author(s)OBJECTIVE: To evaluate the pattern of vision loss and genotype-phenotype correlations in WFS1-associated optic neuropathy (WON). DESIGN: Multicenter cohort study. METHODS: The study involved 37 patients with WON carrying pathogenic or candidate pathogenic WFS1 variants. Genetic and clinical data were retrieved from the medical records. Thirteen patients underwent additional comprehensive ophthalmologic assessment. Deep phenotyping involved visual electrophysiology and advanced psychophysical testing with a complementary metabolomic study. Main Outcome Measures: WFS1 variants, functional and structural optic nerve and retinal parameters, and metabolomic profile. RESULTS: Twenty-two recessive and 5 dominant WFS1 variants were identified. Four variants were novel. All WFS1 variants caused loss of macular retinal ganglion cells (RGCs) as assessed by optical coherence tomography (OCT) and visual electrophysiology. Advanced psychophysical testing indicated involvement of the major RGC subpopulations. Modeling of vision loss showed an accelerated rate of deterioration with increasing age. Dominant WFS1 variants were associated with abnormal reflectivity of the outer plexiform layer (OPL) on OCT imaging. The dominant variants tended to cause less severe vision loss compared with recessive WFS1 variants, which resulted in more variable phenotypes ranging from isolated WON to severe multisystem disease depending on the WFS1 alleles. The metabolomic profile included markers seen in other neurodegenerative diseases and type 1 diabetes mellitus. CONCLUSIONS: WFS1 variants result in heterogenous phenotypes influenced by the mode of inheritance and the disease-causing alleles. Biallelic WFS1 variants cause more variable, but generally more severe, vision and RGC loss compared with heterozygous variants. Abnormal cleftlike lamination of the OPL is a distinctive OCT feature that strongly points toward dominant WON.


Publication metadata

Author(s): Majander A, Jurkute N, Burte F, Brock K, Joao C, Huang H, Neveu MM, Chan CM, Duncan HJ, Kelly S, Burkitt-Wright E, Khoyratty F, Lai YT, Subash M, Chinnery PF, Bitner-Glindzicz M, Arno G, Webster AR, Moore AT, Michaelides M, Stockman A, Robson AG, Yu-Wai-Man P

Publication type: Article

Publication status: Published

Journal: American Journal of Ophthalmology

Year: 2022

Volume: 241

Pages: 9-27

Print publication date: 01/09/2022

Online publication date: 22/04/2022

Acceptance date: 13/04/2022

Date deposited: 04/07/2023

ISSN (print): 0002-9394

ISSN (electronic): 1879-1891

Publisher: Elsevier Inc.

URL: https://doi.org/10.1016/j.ajo.2022.04.003

DOI: 10.1016/j.ajo.2022.04.003

PubMed id: 35469785


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
099173/Z/12/Z
212219/Z/18/Z
5045/46
AS-PG-18b-022
BB/R019487/1
BRC-1215-20014
G1002570
Fight for Sight (UK)
GR001203
MC_UU_00015/9
Moorfields Eye Charity
MR/S035699/1
MR/S005021/1Medical Research Council (MRC)
NIHR301696
NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust
NIHR-BRC
Retina, UK
RPG-2018-408
the Addenbrooke’s Charitable Trust
the Isaac Newton Trust (UK)
the National Eye Research Centre (UK)
the UK NIHR as part of the Rare Diseases Translational Research Collaboration
UCL Institute of Ophthalmology
SAC051
Suomen Silmätutkimusseura ry:n Apurahasäätiö
the Foundation Fighting Blindness (USA)
the International Foundation for Optic Nerve Disease (IFOND)
the NIHR-BRC at Great Ormond Street Hospital Institute of Child Health
the NIHR-BRC at Moorfields Eye Hospital
the NIHR-BRC based at Cambridge University Hospitals NHS Foundation Trust

Share